Table 2.
The dosage of antidepressants between active and sham rTMS group.
| Antidepressants | Baseline | 4 week treatment | 4 week follow-up |
|---|---|---|---|
| Sertraline | |||
| Active rTMS | 40.91 ± 12.61 | 177.27 ± 23.60 | 184.09 ± 20.21 |
| Sham rTMS | 46.43 ± 9.45 | 182.14 ± 18.90 | 196.43 ± 9.45 |
| t/z | −0.990 | −0.459 | −1.746 |
| P | 0.337 | 0.653 | 0.100 |
| Escitalopram | |||
| Active rTMS | 9.69 ± 0.85 | 19.69 ± 1.25 | 19.69 ± 1.25 |
| Sham rTMS | 8.75 ± 1.89 | 20.00 ± 0.00 | 20.00 ± 0.00 |
| t/z | 1.694 | −0.669 | −0.669 |
| P | 0.104 | 0.492 | 0.492 |
rTMS, repetitive transcranial magnetic stimulation.